Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Incidence, prevalence and clinical impact of supraventricular tachycardia in group I pulmonary hypertension
Session:
Posters (Sessão 3 - Écran 6) - Hipertensão pulmonar
Speaker:
Oliveira Baltazar
Congress:
CPC 2023
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
Subtheme:
21.7 Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure - Other
Session Type:
Pósters Electrónicos
FP Number:
---
Authors:
Oliveira Baltazar; Sofia Alegria; Ana Rita Pereira; Paula Fazendas; Filipa Ferreira; Debora Repolho; Alexandra Briosa; João Grade; Barbara Ferreira; Mariana Martinho; João Luz; Nazar; Helder Pereira
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Introduction and purpose:</strong> Tachyarrhythmias, especially supraventricular tachycardia (SVT), have a negative impact on the clinical course of pulmonary hypertension (PH). In most cases, the episodes may be associated with significant clinical deterioration, including worsening of symptoms, functional capacity, often being associated with increased hospitalizations and consequently poor prognosis. The objective of this work was to characterize the population of patients with group 1 PH and SVT and what is its prognostic impact.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Methodology:</strong> retrospective study carried out in a reference center between 2014 and 2022 including patients with group 1 PH and SVT.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Results:</strong> we identified 43 patients with group 1 PH with a mean age of 53.63 ± 2.12 years, 81.4% were and female and, 37.2% associated congenital heart disease in basal evaluation, 53.5% were in functional class (FC) 3, average of the 6-minute walk test (6MWT) was 405.3±18.8 meters, During a mean follow-up (FUP) time of 5 ± 2.47 years. The incidence of SVT was 27.9% and paroxysmal atrial fibrillation was the most prevalent arrhythmia, most of which converted to sinus rhythm. Durin the FUP there was a significant difference in 6MWT (without SVT 415 vs SVT 305 p < 0.05) and final NTproBNP (without SVT 231pg/mL vs SVT 1410 pg/mL p .001) which reflects clinical worsening in the SVT group. The presence of SVT was associated with higher mortality (without SVT 0 vs SVT 3 patients p 004). We found no statistically significant difference in the number of admissions in the two groups due to the reduced number of cases. We did not find statistically significant differences in relation to initial hemodynamic parameters, well as functional class.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Conclusion:</strong> in this population, the presence of SVT was associated with worsening performance in the 6MWT, NTproBNP and mortality. In patients with PH, tachyarrhythmias, in addition to being a marker of advanced disease, also seems to be associated with a worse prognosis, and the early detection and management is fundamental in the treatment of these patients. </span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site